• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对哮喘临床表现及治疗反应的影响。

Effect of obesity on clinical presentation and response to treatment in asthma.

作者信息

Dixon Anne E, Shade David M, Cohen Rubin I, Skloot Gwen S, Holbrook Janet T, Smith Lewis J, Lima John J, Allayee Hooman, Irvin Charles G, Wise Robert A

机构信息

University of Vermont, Burlington, VT 05401, USA.

出版信息

J Asthma. 2006 Sep;43(7):553-8. doi: 10.1080/02770900600859123.

DOI:10.1080/02770900600859123
PMID:16939998
Abstract

Obesity is a risk factor for being diagnosed with asthma, but there is conflicting evidence on whether obesity is a risk factor for lung function abnormalities characteristic of asthma. We studied a cohort of 488 subjects, 47% of whom were obese. Obese and non-obese subjects with asthma had similar airflow limitation and bronchodilator responsiveness, but obese participants had increased sleep disturbance and gastroesophageal reflux disease, higher cytokine levels, and a trend towards increased exacerbations when treated with theophylline. Obese and non-obese asthmatics have similar lung function abnormalities, but comorbidities and altered responses to medications may significantly affect asthma control in obese people.

摘要

肥胖是被诊断为哮喘的一个风险因素,但关于肥胖是否是哮喘特征性肺功能异常的风险因素,证据存在矛盾。我们研究了一个由488名受试者组成的队列,其中47%为肥胖者。患有哮喘的肥胖和非肥胖受试者具有相似的气流受限和支气管扩张剂反应性,但肥胖参与者有更多的睡眠障碍和胃食管反流病、更高的细胞因子水平,并且在接受茶碱治疗时病情加重的趋势增加。肥胖和非肥胖哮喘患者有相似的肺功能异常,但合并症和对药物的反应改变可能会显著影响肥胖人群的哮喘控制。

相似文献

1
Effect of obesity on clinical presentation and response to treatment in asthma.肥胖对哮喘临床表现及治疗反应的影响。
J Asthma. 2006 Sep;43(7):553-8. doi: 10.1080/02770900600859123.
2
Sleep quality in asthma: results of a large prospective clinical trial.哮喘患者的睡眠质量:一项大型前瞻性临床试验的结果
J Asthma. 2008 Apr;45(3):183-9. doi: 10.1080/02770900801890224.
3
Prevalence of alpha-1 antitrypsin deficiency in poorly controlled asthma--results from the ALA-ACRC low-dose theophylline trial.
J Asthma. 2007 Oct;44(8):605-8. doi: 10.1080/02770900701540028.
4
Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.沙美特罗/丙酸氟替卡松与孟鲁司特治疗儿童哮喘的疗效和耐受性:一项前瞻性、随机、双盲、双模拟、平行组研究。
Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.
5
"Inferiority complex" for a reason.
Pediatrics. 2006 Feb;117(2):588-90; author reply 590-1. doi: 10.1542/peds.2005-2495.
6
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.三种控制方案用于轻度至中度持续性儿童哮喘的长期比较:儿童哮喘控制试验
J Allergy Clin Immunol. 2007 Jan;119(1):64-72. doi: 10.1016/j.jaci.2006.09.042. Epub 2006 Nov 30.
7
Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.肥胖对中度哮喘患者使用氟替卡松联合或不联合沙美特罗治疗反应的影响。
Respir Med. 2007 Nov;101(11):2240-7. doi: 10.1016/j.rmed.2007.06.031. Epub 2007 Aug 8.
8
Effect of obesity on breathlessness and airway responsiveness to methacholine in non-asthmatic subjects.肥胖对非哮喘患者呼吸急促及气道对乙酰甲胆碱反应性的影响。
Int J Obes (Lond). 2008 Mar;32(3):502-9. doi: 10.1038/sj.ijo.0803752. Epub 2007 Oct 23.
9
[The efficacy of intravenous theophylline injection for treatment of acute exacerbations of bronchial asthma].静脉注射茶碱注射液治疗支气管哮喘急性加重的疗效
Arerugi. 2002 Apr;51(4):379-82.
10
Airway inflammation in obese and nonobese patients with difficult-to-treat asthma.肥胖和非肥胖的难治性哮喘患者的气道炎症
Allergy. 2008 May;63(5):570-4. doi: 10.1111/j.1398-9995.2007.01597.x.

引用本文的文献

1
Role of body anthropometry in severe asthmatic patients: Evidences from the Severe Asthma Network in Italy (SANI) registry.身体人体测量学在重度哮喘患者中的作用:来自意大利重度哮喘网络(SANI)登记处的证据。
World Allergy Organ J. 2025 May 5;18(5):101056. doi: 10.1016/j.waojou.2025.101056. eCollection 2025 May.
2
Combined Exercise and Diet Induce Airway Hyperreactivity While Reducing Liver Steatosis in Mice with Diet-Induced Obesity.联合运动和饮食可诱导饮食诱导肥胖小鼠的气道高反应性,同时减少肝脏脂肪变性。
Nutrients. 2024 Jul 3;16(13):2129. doi: 10.3390/nu16132129.
3
The Role of Peptides in Asthma-Obesity Phenotype.
肽在哮喘-肥胖表型中的作用。
Int J Mol Sci. 2024 Mar 12;25(6):3213. doi: 10.3390/ijms25063213.
4
Management of the pediatric patient with asthma and obesity.小儿哮喘合并肥胖患者的管理。
Ann Allergy Asthma Immunol. 2024 Jan;132(1):30-39. doi: 10.1016/j.anai.2023.10.001. Epub 2023 Oct 10.
5
Allergic Diseases and Childhood Obesity: A Detrimental Link?过敏性疾病与儿童肥胖:一种有害联系?
Biomedicines. 2023 Jul 22;11(7):2061. doi: 10.3390/biomedicines11072061.
6
Frequency and Functional Consequences of Low Appendicular Lean Mass and Sarcopenic Obesity in Patients with Asthma Referred for Pulmonary Rehabilitation.哮喘患者行肺康复治疗时四肢骨骼肌质量低和肌少症性肥胖的发生率及其功能后果。
Obes Facts. 2023;16(5):435-446. doi: 10.1159/000531196. Epub 2023 May 25.
7
Prevalence of Overweight and Obesity and Their Impact on Spirometry Parameters in Patients with Asthma: A Multicentre, Retrospective Study.超重和肥胖的患病率及其对哮喘患者肺量计参数的影响:一项多中心回顾性研究。
J Clin Med. 2023 Feb 25;12(5):1843. doi: 10.3390/jcm12051843.
8
Subgroup Analysis of a Randomized Trial of the Effects of Positive Messaging on Patient-Reported Outcomes with Asthma - Effect of Obesity.一项关于积极信息对哮喘患者报告结局影响的随机试验的亚组分析——肥胖的影响。
J Asthma Allergy. 2022 Dec 5;15:1743-1751. doi: 10.2147/JAA.S336945. eCollection 2022.
9
Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity.罗氟司特可能会增加肥胖患者因治疗控制不佳的哮喘而恶化的风险。
Ann Am Thorac Soc. 2023 Feb;20(2):206-214. doi: 10.1513/AnnalsATS.202204-368OC.
10
Role of Obesity in Inflammation and Remodeling of Asthmatic Airway.肥胖在哮喘气道炎症和重塑中的作用。
Life (Basel). 2022 Jun 23;12(7):948. doi: 10.3390/life12070948.